Global Assisted Reproductive Technology 麻豆原创 Growth (Status and Outlook) 2024-2030

Publication ID:

LPI03240453

Publication Date:

March 1, 2024

Pages:

106

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Assisted Reproductive Technology market size was valued at US$ 45630 million in 2023. With growing demand in downstream market, the Assisted Reproductive Technology is forecast to a readjusted size of US$ 57350 million by 2030 with a CAGR of 3.3% during review period.
The research report highlights the growth potential of the global Assisted Reproductive Technology market. Assisted Reproductive Technology are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Assisted Reproductive Technology. 麻豆原创 players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Assisted Reproductive Technology market.
Assisted reproductive technology (ART) is a wide range of procedures that are used to treat infertility in men and women. Generally, ART procedures include techniques, such as IVF, ZIFT, GIFT, ICSI, and artificial insemination, which help individuals to conceive a child.
The analysts forecast the global assisted reproductive technology market to grow at a CAGR of 4.11% during the period 2017-2021.
Key Features:
The report on Assisted Reproductive Technology market reflects various aspects and provide valuable insights into the industry.
麻豆原创 Size and Growth: The research report provide an overview of the current size and growth of the Assisted Reproductive Technology market. It may include historical data, market segmentation by Type (e.g., General, Fertility Medication), and regional breakdowns.
麻豆原创 Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Assisted Reproductive Technology market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Assisted Reproductive Technology market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Assisted Reproductive Technology industry. This include advancements in Assisted Reproductive Technology technology, Assisted Reproductive Technology new entrants, Assisted Reproductive Technology new investment, and other innovations that are shaping the future of Assisted Reproductive Technology.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Assisted Reproductive Technology market. It includes factors influencing customer ' purchasing decisions, preferences for Assisted Reproductive Technology product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Assisted Reproductive Technology market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Assisted Reproductive Technology market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Assisted Reproductive Technology market.
麻豆原创 Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Assisted Reproductive Technology industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Assisted Reproductive Technology market.
麻豆原创 Segmentation:
Assisted Reproductive Technology market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
General
Fertility Medication
In Vitro Fertilization
Others
Segmentation by application
Fertility Clinics
Hospitals
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Vitrolife
Ferring Pharmaceuticals
Irvine Scientific
Cook Medical
CellCura
EMD Serono
Esco Micro
IKS International (Gonagen Medikal)
INVO Bioscience
IVFtech
Smiths Medical

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Assisted Reproductive Technology 麻豆原创 Size 2019-2030
2.1.2 Assisted Reproductive Technology 麻豆原创 Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Assisted Reproductive Technology Segment by Type
2.2.1 General
2.2.2 Fertility Medication
2.2.3 In Vitro Fertilization
2.2.4 Others
2.3 Assisted Reproductive Technology 麻豆原创 Size by Type
2.3.1 Assisted Reproductive Technology 麻豆原创 Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Assisted Reproductive Technology 麻豆原创 Size 麻豆原创 Share by Type (2019-2024)
2.4 Assisted Reproductive Technology Segment by Application
2.4.1 Fertility Clinics
2.4.2 Hospitals
2.4.3 Others
2.5 Assisted Reproductive Technology 麻豆原创 Size by Application
2.5.1 Assisted Reproductive Technology 麻豆原创 Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Assisted Reproductive Technology 麻豆原创 Size 麻豆原创 Share by Application (2019-2024)
3 Assisted Reproductive Technology 麻豆原创 Size by Player
3.1 Assisted Reproductive Technology 麻豆原创 Size 麻豆原创 Share by Players
3.1.1 Global Assisted Reproductive Technology Revenue by Players (2019-2024)
3.1.2 Global Assisted Reproductive Technology Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Assisted Reproductive Technology Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Assisted Reproductive Technology by Regions
4.1 Assisted Reproductive Technology 麻豆原创 Size by Regions (2019-2024)
4.2 Americas Assisted Reproductive Technology 麻豆原创 Size Growth (2019-2024)
4.3 APAC Assisted Reproductive Technology 麻豆原创 Size Growth (2019-2024)
4.4 Europe Assisted Reproductive Technology 麻豆原创 Size Growth (2019-2024)
4.5 Middle East & Africa Assisted Reproductive Technology 麻豆原创 Size Growth (2019-2024)
5 Americas
5.1 Americas Assisted Reproductive Technology 麻豆原创 Size by Country (2019-2024)
5.2 Americas Assisted Reproductive Technology 麻豆原创 Size by Type (2019-2024)
5.3 Americas Assisted Reproductive Technology 麻豆原创 Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Assisted Reproductive Technology 麻豆原创 Size by Region (2019-2024)
6.2 APAC Assisted Reproductive Technology 麻豆原创 Size by Type (2019-2024)
6.3 APAC Assisted Reproductive Technology 麻豆原创 Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Assisted Reproductive Technology by Country (2019-2024)
7.2 Europe Assisted Reproductive Technology 麻豆原创 Size by Type (2019-2024)
7.3 Europe Assisted Reproductive Technology 麻豆原创 Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Assisted Reproductive Technology by Region (2019-2024)
8.2 Middle East & Africa Assisted Reproductive Technology 麻豆原创 Size by Type (2019-2024)
8.3 Middle East & Africa Assisted Reproductive Technology 麻豆原创 Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Assisted Reproductive Technology 麻豆原创 Forecast
10.1 Global Assisted Reproductive Technology Forecast by Regions (2025-2030)
10.1.1 Global Assisted Reproductive Technology Forecast by Regions (2025-2030)
10.1.2 Americas Assisted Reproductive Technology Forecast
10.1.3 APAC Assisted Reproductive Technology Forecast
10.1.4 Europe Assisted Reproductive Technology Forecast
10.1.5 Middle East & Africa Assisted Reproductive Technology Forecast
10.2 Americas Assisted Reproductive Technology Forecast by Country (2025-2030)
10.2.1 United States Assisted Reproductive Technology 麻豆原创 Forecast
10.2.2 Canada Assisted Reproductive Technology 麻豆原创 Forecast
10.2.3 Mexico Assisted Reproductive Technology 麻豆原创 Forecast
10.2.4 Brazil Assisted Reproductive Technology 麻豆原创 Forecast
10.3 APAC Assisted Reproductive Technology Forecast by Region (2025-2030)
10.3.1 China Assisted Reproductive Technology 麻豆原创 Forecast
10.3.2 Japan Assisted Reproductive Technology 麻豆原创 Forecast
10.3.3 Korea Assisted Reproductive Technology 麻豆原创 Forecast
10.3.4 Southeast Asia Assisted Reproductive Technology 麻豆原创 Forecast
10.3.5 India Assisted Reproductive Technology 麻豆原创 Forecast
10.3.6 Australia Assisted Reproductive Technology 麻豆原创 Forecast
10.4 Europe Assisted Reproductive Technology Forecast by Country (2025-2030)
10.4.1 Germany Assisted Reproductive Technology 麻豆原创 Forecast
10.4.2 France Assisted Reproductive Technology 麻豆原创 Forecast
10.4.3 UK Assisted Reproductive Technology 麻豆原创 Forecast
10.4.4 Italy Assisted Reproductive Technology 麻豆原创 Forecast
10.4.5 Russia Assisted Reproductive Technology 麻豆原创 Forecast
10.5 Middle East & Africa Assisted Reproductive Technology Forecast by Region (2025-2030)
10.5.1 Egypt Assisted Reproductive Technology 麻豆原创 Forecast
10.5.2 South Africa Assisted Reproductive Technology 麻豆原创 Forecast
10.5.3 Israel Assisted Reproductive Technology 麻豆原创 Forecast
10.5.4 Turkey Assisted Reproductive Technology 麻豆原创 Forecast
10.5.5 GCC Countries Assisted Reproductive Technology 麻豆原创 Forecast
10.6 Global Assisted Reproductive Technology Forecast by Type (2025-2030)
10.7 Global Assisted Reproductive Technology Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Vitrolife
11.1.1 Vitrolife Company Information
11.1.2 Vitrolife Assisted Reproductive Technology Product Offered
11.1.3 Vitrolife Assisted Reproductive Technology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.1.4 Vitrolife Main Business Overview
11.1.5 Vitrolife Latest Developments
11.2 Ferring Pharmaceuticals
11.2.1 Ferring Pharmaceuticals Company Information
11.2.2 Ferring Pharmaceuticals Assisted Reproductive Technology Product Offered
11.2.3 Ferring Pharmaceuticals Assisted Reproductive Technology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.2.4 Ferring Pharmaceuticals Main Business Overview
11.2.5 Ferring Pharmaceuticals Latest Developments
11.3 Irvine Scientific
11.3.1 Irvine Scientific Company Information
11.3.2 Irvine Scientific Assisted Reproductive Technology Product Offered
11.3.3 Irvine Scientific Assisted Reproductive Technology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.3.4 Irvine Scientific Main Business Overview
11.3.5 Irvine Scientific Latest Developments
11.4 Cook Medical
11.4.1 Cook Medical Company Information
11.4.2 Cook Medical Assisted Reproductive Technology Product Offered
11.4.3 Cook Medical Assisted Reproductive Technology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.4.4 Cook Medical Main Business Overview
11.4.5 Cook Medical Latest Developments
11.5 CellCura
11.5.1 CellCura Company Information
11.5.2 CellCura Assisted Reproductive Technology Product Offered
11.5.3 CellCura Assisted Reproductive Technology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.5.4 CellCura Main Business Overview
11.5.5 CellCura Latest Developments
11.6 EMD Serono
11.6.1 EMD Serono Company Information
11.6.2 EMD Serono Assisted Reproductive Technology Product Offered
11.6.3 EMD Serono Assisted Reproductive Technology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.6.4 EMD Serono Main Business Overview
11.6.5 EMD Serono Latest Developments
11.7 Esco Micro
11.7.1 Esco Micro Company Information
11.7.2 Esco Micro Assisted Reproductive Technology Product Offered
11.7.3 Esco Micro Assisted Reproductive Technology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.7.4 Esco Micro Main Business Overview
11.7.5 Esco Micro Latest Developments
11.8 IKS International (Gonagen Medikal)
11.8.1 IKS International (Gonagen Medikal) Company Information
11.8.2 IKS International (Gonagen Medikal) Assisted Reproductive Technology Product Offered
11.8.3 IKS International (Gonagen Medikal) Assisted Reproductive Technology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.8.4 IKS International (Gonagen Medikal) Main Business Overview
11.8.5 IKS International (Gonagen Medikal) Latest Developments
11.9 INVO Bioscience
11.9.1 INVO Bioscience Company Information
11.9.2 INVO Bioscience Assisted Reproductive Technology Product Offered
11.9.3 INVO Bioscience Assisted Reproductive Technology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.9.4 INVO Bioscience Main Business Overview
11.9.5 INVO Bioscience Latest Developments
11.10 IVFtech
11.10.1 IVFtech Company Information
11.10.2 IVFtech Assisted Reproductive Technology Product Offered
11.10.3 IVFtech Assisted Reproductive Technology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.10.4 IVFtech Main Business Overview
11.10.5 IVFtech Latest Developments
11.11 Smiths Medical
11.11.1 Smiths Medical Company Information
11.11.2 Smiths Medical Assisted Reproductive Technology Product Offered
11.11.3 Smiths Medical Assisted Reproductive Technology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.11.4 Smiths Medical Main Business Overview
11.11.5 Smiths Medical Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.